NETs	neuroendocrine tumors
SEER	Surveillance, Epidemiology, and End Results Program
NENs	neuroendocrine neoplasms
GEP-NET	gastroenteropancreatic neuroendocrine tumors
GEP	gastroenteropancreatic
NECs	neuroendocrine carcinomas
WHO	World Health Organization
SSRTs	somatostatin receptors
PRRT	peptide receptor radionuclide therapy
NELMs	neuroendocrine liver metastases
pNETs	pancreatic neuroendocrine neoplasms
OS	overall survival
PFS	progression-free survival
DFS	disease-free survival
RCTs	randomized trials
TTP	time to progression
ALPPS	Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy
OLT	orthotopic liver transplantation
LT	liver transplantation
SB-NETs	small bowel neuroendocrine tumors
CHD	carcinoid heart disease
CS	carcinoid syndrome
SSAs	somatostatin analogues
mTOR	mammalian target of rapamycin
VEGF	vascular endothelial growth factor
LRTs	locoregional therapies
SIRT	selective internal radiation therapy
TARE	transarterial radioembolization
MDT	multidisciplinary team
MELD	model of End-Stage liver Disease
ESMO	European Society for Medical Oncology
UNOS/OPTN	united network for organ sharing/organ procurement and transplantation Network
ENETs	European Neuroendocrine Tumor Society
NANETs	North America Neuroendocrine Tumor Society
PVE	portal vein embolization